Hormonal therapy and chemotherapy in patients with hormone-sensitive prostate cancer

by R. A. Gafanov
Published 2016-05-01

Neoadjuvant hormonal therapy with bicalutamide 150 mg before radical treatment in patients with localized and locally advanced prostate cancer

by A. D. Kaprin, R. A. Gafanov, M. Halil Farzat
Published 2020-02-01

Experience of using atezolizumab in 1st line therapy of metastatic urothelial cancer

by R. A. Gafanov, A. G. Dzidzaria, V. A. Rebrikova
Published 2019-10-01

Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progres...

by R A Gafanov, S A Ivanov, S V Fastovets, T K Isaev
Published 2012-06-01

Metastatic castration-resistant prostate cancer: a current view on drug therapy and alternative tumor cell regulation

by R. A. Gafanov, S. V. Garmash, I. B. Kravtsov, S. V. Fastovets
Published 2018-04-01

MODERN POSSIBILITIES OF THERAPY WITH INHIBITORS OF CONTROL POINTS IN METASTATIC UROTHELIAL CANCER

by R. A. Gafanov, S. V. Garmash, I. B. Kravtsov, S. V. Fastovets
Published 2018-03-01

Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection

by R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets
Published 2019-01-01

Choice of treatment options for metastatic hormone-sensitive prostate cancer

by R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets
Published 2020-12-01

Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma?

by R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets
Published 2020-11-01

Strontium-89 Chloride in Combined Treatment of Hormone Resistant Prostatic Cancer

by A. D. Kaprin, Yu. N. Smirnov, R. A. Gafanov, A. A. Kostin
Published 2020-02-01

Current view: leiomyosarcoma of the veins of the retroperitoneum. Case histories review

by A. Yu. Pavlov, S. V. Garmash, T. K. Isaev, R. A. Gafanov, I. B. Kravtsov
Published 2016-06-01

DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY

by A. Y. Pavlov, R. A. Gafanov, S. V. Fastovets, A. D. Tsybulsky, T. K. Isaev
Published 2016-02-01

Drug treatment opportunities of the elderly patients with the metastatic castration-resistant prostate cancer

by V. A. Solodkiy, A. Yu. Pavlov, R. A. Gafanov, S. V. Garmash, I. V. Kravtsov, S. V. Fastovets, A. K. Ivashin
Published 2017-04-01

An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia

by B. Ya. Alekseev, K. M. Nyushko, R. A. Gafanov, A. A. Kirichek, Yu. V. Anzhiganova, E. I. Kopyltsov, Yu. Yu. Sundui, V. B. Matveev
Published 2020-11-01

Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer

by B. Ya. Alekseev, V. B. Matveev, I. G. Rusakov, M. I. Volkova, O. B. Karjakin, L. V. Bolotina, G. P. Kolesnikov, E. I. Kopylcov, B. Sh. Kamolov, K. M. Nyushkov, V. A. Atduev, P. A. Karnauch, R. V. Smirnov, O. G. Tonacheva, D. V. Tevs, A. A. Izmailov, A. V. Govorov, R. A. Gafanov, S. V. Mishugin, A. O. Karyakin
Published 2016-09-01